Archive | BIOgraph

Kythera (KYTH) Soars on Phase III Fat Drug Update 1

Chin-Up and Out! KYTH traded 2.58M shares today closing near its gap up 25% this morning at $41.95 . There was distribution of stock probably from early investors to funds and retail. The market cap is $774M. As of June 30,2013 reporting the Company had Shareholder equity of $45.8M and Cash of about $76M. Insiders […]

Continue Reading

FED No Change: Market Down 1% as Less Monetary Accommodation Likely in Future

Downside Risk to Economy Diminished So Less “Extreme Monetary Policy” In the Future? Market Stable with downward bias :S&P flat to down 18 pts-10 Year Bond Yield At 2.28% up 3.9% FED Is Optimistic ¬†about the economy: housing, consumer sentiment, financial backdrop but with fiscal drag. Bond purchases are tied to the economy. The FED […]

Continue Reading

Biotech Bull Market Momentum is Easing So Watch High Flyers: AEGR,CLVS etc- Update 6/16

Biotech Sell-Off Continues Nothing dramatic but the overall weakness in biopharmaceutical stocks is continuing today despite a strong performance by NASDAQ up 1.2% at 3464. With biotech having one of it best years of all time, profit taking is expected. The most popular ETFs IBB down 0.4% and XBI down 0.4% are weak but are […]

Continue Reading